Platelet BioGenesis

About:

Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.

Website: https://www.plateletbiogenesis.com

Top Investors: Qiming Venture Partners, National Institute of Allergy and Infectious Diseases, Massachusetts Life Sciences Center, U.S. Department of Defense, Vivo Capital

Description:

Platelet BioGenesis specializes in the fields of biotechnology, platelets, and drug discovery. They discover a new category in therapeutics. The company is developing technology to produce donor-independent human platelets from human induced pluripotent stem cells.

Total Funding Amount:

$132M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Watertown, Massachusetts, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)plateletbiogenesis.com

Founders:

Jonathan Thon, Joseph Italiano, Sven Karlsson

Number of Employees:

11-50

Last Funding Date:

2021-11-04

IPO Status:

Private

Industries: